Previous Nav
Net Change on 19-09-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
SUN PHARMACEUTICAL INDUSTRIES LTD.
Max Healthcare Institute Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Cipla Ltd.
Divis Laboratories Ltd.
Triparty Repo
Apollo Hospitals Enterprise Ltd.
Fortis Healthcare India Ltd
Lupin Ltd.
JUBILANT PHARMOVA LIMITED
Gland Pharma Limited
ASTER DM HEALTHCARE LTD
ANTHEM BIOSCIENCES LTD
Ami Organics Ltd
Dr.Reddy's Laboratories Ltd.
MANKIND PHARMA LTD
Glenmark Pharmaceuticals Ltd
KRISHNA INSTITUTE OF MEDICAL
Aurobindo Pharma Ltd.
SAI LIFE SCIENCES LIMITED
Ajanta Pharma Ltd.
INNOVA CAPTABS LTD
Krsnaa Diagnostics Ltd
Zydus Lifesciences Ltd.
Marksans Pharma Ltd
ORCHID PHARMA LIMITED
LAXMI DENTAL LIMITED
RAINBOW CHILDRENS MEDICARE LTD
Alkem Laboratories Ltd.
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD
HIKAL LTD
Net Current Assets/(Liabilities)
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Medical Equipment/Supplies/Accessories
Cash
Equity
Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹466.92 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.
The NAV of Kotak Healthcare Fund ended up ₹0.03(0.23%)yesterday to ₹13.784.
Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and
The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.
27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051